Event JSON
{
"id": "7e135a35fe66a852687ffe85b692164bd81a71288d75d2775f05ca3c2d6c62d6",
"pubkey": "a3af17104f91f7f9b5667b14717d1d434931195e4c6e075b7dc13d8ed71bc46f",
"created_at": 1720562339,
"kind": 1,
"tags": [
[
"imeta",
"url https://files.mastodon.social/media_attachments/files/112/758/773/428/995/167/original/5c7da55c46393122.jpg",
"m image/jpeg"
],
[
"proxy",
"https://mastodon.social/@arstechnica/112758773477745994",
"web"
],
[
"proxy",
"https://mastodon.social/users/arstechnica/statuses/112758773477745994",
"activitypub"
],
[
"L",
"pink.momostr"
],
[
"l",
"pink.momostr.activitypub:https://mastodon.social/users/arstechnica/statuses/112758773477745994",
"pink.momostr"
],
[
"expiration",
"1723154344"
]
],
"content": "FTC blasts drug middlemen for “inflating” costs, “squeezing” pharmacies\n\nPharmacy benefit managers (PBMs) are key part of US's high drug costs, report finds.\n\nhttps://arstechnica.com/tech-policy/2024/07/ftc-blasts-drug-middlemen-for-inflating-costs-squeezing-pharmacies/?utm_brand=arstechnica\u0026utm_social-type=owned\u0026utm_source=mastodon\u0026utm_medium=social\nhttps://files.mastodon.social/media_attachments/files/112/758/773/428/995/167/original/5c7da55c46393122.jpg\n",
"sig": "b592781459bff551f4a30facbd250da8b2709516f92e330767f3dcd42209126c395252f4c048a4ce136005c297d07623f8f0b7dafedfff14ab859687f656b6b9"
}